The rare variants shown to associate with sporadic AD include potentially damaging and loss of function mutations, suggesting that careful assessment has to be considered for clinical practice and patient feedback along with the already established variation in APOE, PSEN1, PSEN2 and APP [117]. This evidence concerns the gene APP and Alzheimer disease.